Estradiol in the Cycle: Normal Ranges, Cycle Day and Interpretation

Estradiol is the most potent oestrogen. In the menstrual cycle it is produced mainly by the granulosa cells of the growing ovarian follicle under the influence of FSH and LH. Estradiol is responsible for rebuilding the uterine lining after menstruation and increasing cervical mucus, and it acts on bone, the cardiovascular system, skin and mood. Its rise in the follicular phase is a signal that the follicle is maturing; when estradiol stays above a certain level for long enough, the pituitary responds with a sudden surge of LH (the LH peak), which triggers ovulation.

After ovulation estradiol dips briefly, and then the corpus luteum produces it together with progesterone - so a smaller, second peak is seen in the luteal phase. At the end of the cycle, as the corpus luteum regresses, estradiol and progesterone fall sharply and menstruation begins. This is why the lowest estradiol values are seen just before the period and in the first days of bleeding, after which the level rises from day to day.

The unit conversion is roughly 1 pg/ml = 3.67 pmol/l. The ranges above are rounded approximate values used in practice; each laboratory gives its own reference intervals, depending on the assay used and the population studied. Always compare your result with the interval for the cycle phase on your own report.

The standard timing is days 2-5 of the cycle (counting from the first day of full bleeding), that is, the early follicular phase. At this time three hormones are usually measured together: estradiol, FSH and LH. This set is used to assess the hypothalamic-pituitary-ovarian axis, for example with irregular cycles, suspected premature ovarian insufficiency, infertility work-up and before treatment. The same rule applies to FSH and LH (described in the sex-hormone entry of our knowledge base): what counts is the cycle day, not the day of the week.

Estradiol and FSH have to be read together. Estradiol in the follicular phase suppresses FSH secretion through negative feedback. When estradiol is unexpectedly high already at the start of the cycle, it can lower FSH and make the FSH value look better than the actual ovarian reserve would suggest. This is one reason early-cycle estradiol is measured alongside FSH rather than on its own. It is also worth remembering that AMH and the antral follicle count on ultrasound tell you more about ovarian reserve than estradiol alone.

Other timings serve other purposes. Estradiol around the expected ovulation is rarely drawn - usually as part of cycle monitoring in a fertility clinic, together with ultrasound. Luteal-phase estradiol is measured only occasionally. With absent periods, when there is no 'first day of the cycle', it is measured at any time, and the result is interpreted in the context of FSH, LH, progesterone and ultrasound.

Estradiol results depend on the method used. Most laboratories use immunoassays (automated), which are fast and cheap but may show cross-reactivity with other steroids and poorer sensitivity at low concentrations. The reference approach is mass spectrometry coupled with chromatography (LC-MS/MS), more specific and sensitive but more expensive and less widely available. A review on the standardisation of steroid hormone assays points out that direct immunoassays suffer from inadequate specificity and sensitivity, and that median 'normal' estradiol values in postmenopausal women differ in the literature by about six-fold.

Practical conclusion: compare results only within the same laboratory and the same method if you are tracking changes over time. Changing laboratory can by itself shift a result. Also watch the units: 120 pg/ml and 440 pmol/l are the same value, and a mix-up of units is a common cause of needless worry.

Low estradiol in the follicular phase can be a sign that the ovaries are under 'low tension' of stimulation. The causes fall into three groups. First, insufficient stimulation from the hypothalamus and pituitary, that is hypogonadotropic hypogonadism: functional hypothalamic amenorrhoea (too little energy intake, intense exercise, stress, weight loss), some pituitary disorders, hyperprolactinaemia. Second, ovarian failure: premature ovarian insufficiency or natural menopause, in which FSH is high and estradiol low. Third, iatrogenic causes: hormonal contraception, drugs that suppress ovulation, chemotherapy.

The Endocrine Society guideline on functional hypothalamic amenorrhoea stresses that it is a form of chronic anovulation with no identifiable organic cause, often associated with stress, weight loss and excessive exercise or a combination of these, and that the diagnosis is one of exclusion. Complications include bone loss and infertility. If low estradiol accompanies absent periods, it needs consultation - not only for fertility but also to protect the bones.

A high estradiol result can be entirely physiological if the test fell just before ovulation - at the pre-ovulatory peak values reach several hundred pg/ml. So the first question is: which day of the cycle was it. If estradiol is raised in the early follicular phase (days 2-5), possible causes include a functional ovarian cyst, earlier follicle recruitment (more common in women over 35), hormonal therapy or ovulation stimulation, pregnancy and, less often, oestrogen-producing tumours. In women with obesity, part of estradiol is formed from androgens in adipose tissue, which can raise its level.

Symptoms of oestrogen excess, such as heavy periods, breast tenderness, swelling or headaches, are non-specific and also occur with normal estradiol, so on their own they do not justify a diagnosis. Conversely, a normal result does not exclude an imbalance between oestrogen and progesterone in a given cycle - progesterone is used to assess ovulation (we write about it in a separate article). A single, 'slightly raised' result should not be interpreted as disease.

Combined hormonal contraception (pills, patch, ring) suppresses the hypothalamic-pituitary-ovarian axis, which lowers the body's own production of estradiol and FSH/LH. An estradiol result during such contraception therefore mainly reflects that suppression rather than natural ovarian secretion, and is not suitable for assessing the cycle, ovulation or ovarian reserve. That is why, when investigating 'cycle hormones', people are usually asked to stop contraception and have tests in a natural cycle, which needs to be discussed with the doctor and covered by another form of contraception in the meantime.

With a hormonal IUD releasing levonorgestrel, some women still ovulate and estradiol shows cyclical changes, but the assessment should take the preparation used into account. In women using estradiol therapy (for example patches, gel or tablets) the result depends on the time since the last dose and the route of administration; in this situation the interpretation is set by the doctor managing the therapy. In both cases the key rule is: tell the laboratory and your doctor about every hormonal preparation you use.

One of the most common misunderstandings is the belief that in perimenopause estradiol 'falls' in a straight line. In reality, early in the menopausal transition cycles may be shorter, FSH rises, and estradiol in ovulatory cycles can be higher than in younger women, with large swings between cycles. Only in the late transition and after menopause does estradiol fall permanently.

What follows? First, in perimenopause a single estradiol is of little use - one cycle may have a high peak and the next a very low one, or none at all. Second, the diagnosis of perimenopause rests mainly on changes in cycle regularity and on symptoms, not on a single hormone result. We describe this in detail in our article on the differences between perimenopause and menopause. Third, with symptoms (hot flushes, sleep disturbance), the decision about treatment rests on the clinical picture - we write about hormone therapy in our article on HRT.

What this text does not cover: it is not a guide to infertility treatment or hormone therapy, gives no individual recommendations and does not replace a consultation. The cited papers have limitations: Stricker's reference study covered 20 young women and one analyser, and Hale et al. assessed a single cycle in small groups - the results illustrate phenomena but do not replace your own laboratory's reference ranges. The estradiol ranges given are rounded and approximate.

Estradiol is one of those tests where ordering is easy and interpretation needs context. Best practice is to measure it together with FSH and LH in the early follicular phase, in the same laboratory, with the cycle day clearly recorded and knowledge of any drugs being used. We advise against buying 'hormone panels' without a clinical question and against deciding on supplements on the basis of one result. If cycles are irregular, symptoms are troublesome or you are planning pregnancy, it is better to go through the work-up according to your doctor's plan than to guess from single numbers.